iRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates

Company Performance - iRhythm Technologies reported a quarterly loss of $0.32 per share, better than the Zacks Consensus Estimate of a loss of $0.53, and an improvement from a loss of $0.61 per share a year ago, resulting in an earnings surprise of +39.62% [1] - The company posted revenues of $186.69 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 7.47%, and up from $148.05 million in the same quarter last year [2] - Over the last four quarters, iRhythm Technologies has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - iRhythm Technologies shares have increased approximately 55.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 8.2% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.38 on revenues of $173 million, and for the current fiscal year, it is -$1.92 on revenues of $695.48 million [7] Industry Outlook - The Medical Info Systems industry, to which iRhythm Technologies belongs, is currently ranked in the top 26% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5]